ISPOR - PBI34 Paying for Curative GENE Therapies: Potential, Barriers and Healthcare Reforms for Risk-Sharing between Payers and Industry in a MULTI-Payer Healthcare System

PBI34 Paying for Curative GENE Therapies: Potential, Barriers and Healthcare Reforms for Risk-Sharing between Payers and Industry in a MULTI-Payer Healthcare System

Abstract

Authors

N. Ruedemann M. Florian M.P. Schoenermark

Full Text Cite This Article

Back to Volume 23, Supplemental S2

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now